Markets see just one rate cut coming in 2025 amid a confluence of strong economic data and the potential for Trump's economic ...

Jill Carey Hall, BofA Global Research head of U.S. small/mid cap strategy, joins CNBC's 'Squawk Box' to discuss outlooks on ...

O Bank of America criou um grupo de especialistas para atender os ultra-ricos, buscando capitalizar as crescentes fileiras de ...

Wednesday's close will mark the end of the first five trading days of the year, a window that historically sets the tone for ...

The company is creating a new team of specialists to better connect advisors and their rich clients with other parts of Bank ...

Hermès has sparred with LVMH before. Fending off the Arnault-owned luxury giant’s takeover attempt eventually led Hermès to ...

Warren Buffett's Berkshire Hathaway owns one of the world's most closely watched stock portfolios. It holds stakes in 46 ...

BofA analyst Alec Stranahan lowered the firm’s price target on Recursion Pharmaceuticals (RXRX) to $10 from $12 and keeps a ...

BofA analyst Alec Stranahan lowered the firm’s price target on Regenxbio (RGNX) to $22 from $25 and keeps a Buy rating on the ...

"Tariffs raise two main concerns," BofA notes. They explain that first is the potential negative impact on global growth and ...

Beaten-down European stocks are luring investors back after a record underperformance versus Wall Street in 2024, as fears ...

To be sure, the stock is still well-liked on Wall Street. Jefferies analysts led by James Heaney named AppLovin a top pick ...